Ab&B Biotech is a series c plus startup. 2 investors tracked. Status: possibledead.
Based in China, Ab&B Biotech is a startup. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Ab&B Bio-Tech is a China-based vaccine company dedicated to the research, development, manufacturing and commercialization of innovative and traditional vaccines adopting new technical methods, with a focus on viral, bacterial, conjugate, subunit, and mRNA vaccines.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.